Taxane drugs, such as paclitaxel and docetaxel, have been associated with scleroderma-like lesions that exhibit unique pathophysiological pathways, including elevated serum interleukin-6 levels, with docetaxel exhibiting more pronounced effects [19]. Here, IL6 is linked to scleroderma.